Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation
Athan Kuliopulos
1
Division of Hematology/Oncology, Molecular Oncology Research Institute, New England Medical Center and Departments of Medicine and Biochemistry Tufts University School of Medicine, Boston, Massachusetts, USA
,
Ramon Mohanlal
2
Vertex Pharmaceutical Company, Inc., Cambridge, Massachusetts, USA
,
Lidija Covic
1
Division of Hematology/Oncology, Molecular Oncology Research Institute, New England Medical Center and Departments of Medicine and Biochemistry Tufts University School of Medicine, Boston, Massachusetts, USA